NYSE - Delayed Quote • USD
Pediatrix Medical Group, Inc. (MD)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 8 |
Avg. Estimate | 0.19 | 0.35 | 1.24 | 1.29 |
Low Estimate | 0.16 | 0.3 | 1.16 | 1.12 |
High Estimate | 0.22 | 0.4 | 1.31 | 1.34 |
Year Ago EPS | 0.23 | 0.39 | 1.26 | 1.24 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 8 |
Avg. Estimate | 499.08M | 508.97M | 2.04B | 2.11B |
Low Estimate | 492.1M | 503.6M | 2.01B | 2.07B |
High Estimate | 504.3M | 514.1M | 2.07B | 2.15B |
Year Ago Sales | 490.78M | 500.58M | 1.99B | 2.04B |
Sales Growth (year/est) | 1.70% | 1.70% | 2.20% | 3.40% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.23 | 0.4 | 0.43 | 0.32 |
EPS Actual | 0.23 | 0.39 | 0.32 | 0.32 |
Difference | 0 | -0.01 | -0.11 | 0 |
Surprise % | 0.00% | -2.50% | -25.60% | 0.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.19 | 0.35 | 1.24 | 1.29 |
7 Days Ago | 0.19 | 0.35 | 1.24 | 1.29 |
30 Days Ago | 0.19 | 0.35 | 1.24 | 1.29 |
60 Days Ago | 0.24 | 0.35 | 1.3 | 1.32 |
90 Days Ago | 0.24 | 0.35 | 1.3 | 1.32 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | MD | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -17.40% | -- | -- | 0.80% |
Next Qtr. | -10.30% | -- | -- | 9.60% |
Current Year | -1.60% | -- | -- | 4.50% |
Next Year | 4.00% | -- | -- | 13.30% |
Next 5 Years (per annum) | -4.58% | -- | -- | 11.09% |
Past 5 Years (per annum) | -16.83% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Jefferies: Hold to Hold | 3/6/2024 |
Maintains | Mizuho: Neutral to Neutral | 2/21/2024 |
Maintains | Truist Securities: Hold to Hold | 2/21/2024 |
Initiated | UBS: Neutral | 11/30/2023 |
Maintains | Truist Securities: Hold to Hold | 10/11/2023 |
Maintains | Truist Securities: Hold | 5/9/2023 |
Related Tickers
CCRN Cross Country Healthcare, Inc.
17.13
+1.48%
MODV ModivCare Inc.
20.13
-3.03%
PNTG The Pennant Group, Inc.
19.89
-0.60%
SEM Select Medical Holdings Corporation
26.43
-0.75%
USPH U.S. Physical Therapy, Inc.
97.49
-0.64%
BKD Brookdale Senior Living Inc.
6.52
+0.93%
HCSG Healthcare Services Group, Inc.
11.70
+1.04%
BKDT Brookdale Senior Living Inc
86.70
0.00%
LFST LifeStance Health Group, Inc.
5.71
+0.35%
GBNHF Greenbrook TMS Inc.
0.0950
+16.56%